← back to search

Andrea L. Neimann

Brigham and Women's Hospital · US
Area of research
Immunology · Rheumatology
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, and Dermatology and Skin Diseases.
h-index
20
citations
7,149
works
56
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
BMJ Open 2022cited by 51position: middledoi
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin
Annals of the Rheumatic Diseases 2022cited by 45position: middledoi
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
The Lancet Rheumatology 2021cited by 24position: middledoi
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
New England Journal of Medicine 2020cited by 420position: middledoi
COVID‐19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease‐Modifying Antirheumatic Drugs on Clinical Outcomes
Arthritis & Rheumatology 2020cited by 112position: middledoi
Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1
Arteriosclerosis Thrombosis and Vascular Biology 2020cited by 76position: middledoi
CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health
Journal of the American Academy of Dermatology 2020cited by 56position: middledoi
Inflammasome Signaling and Impaired Vascular Health in Psoriasis
Arteriosclerosis Thrombosis and Vascular Biology 2019cited by 93position: middledoi
Interleukin‐17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin‐25–Driven Intestinal Inflammation
Arthritis & Rheumatology 2019cited by 76position: middledoi
Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology–Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients
Current Rheumatology Reports 2017cited by 53position: lastdoi
Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
Arthritis & Rheumatology 2014cited by 802position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

José U. Scher · NYU Langone Health9 papers (2014–2022)Rebecca H. Haberman · New York University4 papers (2020–2022)Michael Garshick · NYU Langone Health3 papers (2019–2020)James G. Krueger · University of Rochester Medical Center3 papers (2019–2020)Edward A. Fisher · Institute for Biomedical Engineering3 papers (2019–2020)Jeffrey S. Berger · JDSU (United States)3 papers (2019–2020)Soumya M. Reddy · New York University3 papers (2014–2019)Julia Manasson · New York University3 papers (2014–2022)Rochelle Castillo · Boston Children's Hospital3 papers (2020–2022)Tessa J. Barrett · NYU Langone Health3 papers (2019–2020)Carles Úbeda · New York University2 papers (2014–2019)Peter Izmirly · NYU Langone Health2 papers (2020–2020)Gary Solomon · New York University2 papers (2019–2020)Di Yan · Beijing University of Agriculture2 papers (2020–2020)Rebecca B. Blank · University School2 papers (2022–2022)Michael Tawil · New York University2 papers (2020–2020)Parvathy V. Girija · New York University2 papers (2019–2022)Michelle Badri · New York University2 papers (2019–2022)Samrachana Adhikari · NYU Langone Health2 papers (2020–2020)Alexis Ogdie · Hospital of the University of Pennsylvania2 papers (2020–2022)